Bertoli, Sarah <br/><br/>
Dexamethasone in hyperleukocytic acute myeloid leukemia.  [electronic resource] 

 -  Haematologica  06 2018 
 - 988-998 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2017.184267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Leukocytosis--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Prognosis<br/>Recurrence<br/>Remission Induction<br/>Treatment Outcome<br/>Young Adult